Details of the Drug
General Information of Drug (ID: DMMCNQI)
Drug Name |
6-Bromo-2-phenyl-chromen-4-one
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
6-Bromoflavone; 1218-80-0; 6-bromo-2-phenyl-4H-chromen-4-one; 6-Bromo-2-phenyl-4H-1-benzopyran-4-one; 6-Bromo-2-phenyl-(4H)-4-benzopyranone; 6-bromo-2-phenylchromen-4-one; 6-Bromo-2-phenyl-chromen-4-one; ACMC-20alzx; AC1LAD8N; MLS002473413; CHEMBL52825; SCHEMBL4449962; ZINC58081; DTXSID00332792; HMS3343M11; HMS2224K05; 5956AH; MFCD00276169; AKOS015889624; MCULE-7797339727; ZB002311; ST059081; SMR001397504; KB-247810; TX-017285; 4H-1-Benzopyran-4-one, 6-bromo-2-phenyl-; K-1651; 6-Bromo-2-phenyl-(4H)-4-benzopyranone, 97%
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 301.13 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 4.7 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||||